These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5763626)

  • 1. Immunologic competence of the liver for production of allergic encephalomyelitis.
    Levine S; Sowinski R
    Arch Pathol; 1969 Feb; 87(2):223-7. PubMed ID: 5763626
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of experimental allergic encephalomyelitis with yeast glucan and methyl palmitate to alter the activity of the reticuloendothelial system.
    Snyder AR; Levine S
    J Reticuloendothel Soc; 1980 Jul; 28(1):49-54. PubMed ID: 6993664
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss of adjuvanticity in rats for the hyperacute form of allergic encephalomyelitis and for reaginic antibody production in mice of a phenotypic variant of Bordetella pertussis.
    Wardlaw AC; Parton R; Bergman RK; Munoz JJ
    Immunology; 1979 Jul; 37(3):539-45. PubMed ID: 500113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of cytotoxicity with experimental allergic encephalomyelitis.
    Allbritton AR; Loan RW
    Cell Immunol; 1975 Sep; 19(1):91-8. PubMed ID: 52410
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells.
    Brostoff SW; Mason DW
    J Immunol; 1984 Oct; 133(4):1938-42. PubMed ID: 6236260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of effector cells in experimental allergic encephalomyelitis by interleukin 2 (IL-2).
    Ortiz-Ortiz L; Weigle WO
    J Immunol; 1982 Apr; 128(4):1545-50. PubMed ID: 6174605
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of carrageenan on the course of experimental allergic encephalomyelitis in the rat].
    Vymazal J; Krásenská-Dlabacová J; Miler I; Malbohan I
    Cesk Neurol Neurochir; 1974 Nov; 37(6):345-8. PubMed ID: 4426099
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperacute allergic encephalomyelitis: adjuvant effect of pertussis vaccines and extracts.
    Levine S; Wenk EJ; Devlin HB; Pieroni RE; Levine L
    J Immunol; 1966 Sep; 97(3):363-8. PubMed ID: 5332650
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of cyclophosphamide suppression of experimental allergic encephalomyelitis in Wistar rats.
    Paterson PY; Hanson MA
    J Immunol; 1969 Oct; 103(4):795-803. PubMed ID: 5349735
    [No Abstract]   [Full Text] [Related]  

  • 10. Transglutaminase levels during development of allergic orchitis.
    Lee JM; Wajda IJ
    J Immunol; 1970 Feb; 104(2):448-54. PubMed ID: 5460948
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMMUNOLOGIC ASPECTS OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN SUSCEPTIBLE AND RESISTANT MICE.
    LEE JM
    Z Immunitats Allergieforsch; 1964 Mar; 126():14-24. PubMed ID: 14185392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of immunoglobulin treatment in rats with experimental allergic encephalomyelitis].
    Mel'nyk VO; Lisianyĭ MI; Biel's'ka LM; Shniakin SA
    Fiziol Zh (1994); 2005; 51(6):37-9. PubMed ID: 16485852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune effector cells. V.A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis.
    Swanborg RH
    J Immunol; 1983 Apr; 130(4):1503-5. PubMed ID: 6187808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA; Kamoun M; Ventura E; Rostami A
    Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune effector cells. VI. Transfer of experimental allergic encephalomyelitis with spleen cells activated in mixed lymphocyte cultures.
    Hayosh NS; Simon LL; Swanborg RH
    J Immunol; 1984 Oct; 133(4):1943-5. PubMed ID: 6236261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathology of allergic encephalomyelitis.
    Brosnan CF; Wisniewski HM
    Prog Clin Biol Res; 1980; 39():379-90. PubMed ID: 7403188
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-brain antibodies and autonomic nervous system mediators in the dynamics of experimental allergic encephalomyelitis].
    Vilkov GA; Khoruzhaia TA
    Biull Eksp Biol Med; 1971 May; 71(5):34-7. PubMed ID: 4398210
    [No Abstract]   [Full Text] [Related]  

  • 19. Both bone marrow- and non-bone marrow-associated factors determine susceptibility to experimental autoimmune encephalomyelitis of BUF and WAG rats.
    van Gelder M; Kinwel-Bohré EP; Mulder AH; van Bekkum DW
    Cell Immunol; 1996 Feb; 168(1):39-48. PubMed ID: 8599838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of protection against the experimental allergic encephalomyelitis in the rabbit].
    Cazzullo CL; Andreola ML; Giordano F; Smeraldi E
    Acta Neurol (Napoli); 1972; 27(3):213-9. PubMed ID: 5068742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.